Introduction to behavioral addictions

American Journal of Drug and Alcohol Abuse

Volumn 36, Issue 5, 2010, Pages 233-241

  Grant, Jon E ^a   Potenza, Marc N ^b   Weinstein, Aviv ^c   Gorelick, David A ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Behavioral addiction; Classification; Diagnosis; Impulse control disorder; Substance use disorder

Indexed keywords

ACETYLCYSTEINE; NALOXONE; NALTREXONE; TOPIRAMATE;

ADDICTION; ALCOHOLISM; BEHAVIOR THERAPY; CLASSIFICATION; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPLEX SEXUAL BEHAVIOR; COMPULSION; COMPULSIVE BUYING; COMPULSIVE GAMBLING; COMPULSIVE SEXUAL BEHAVIOR; COMPULSIVE SKIN PRICKING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; FAMILY HISTORY; HEREDITY; HUMAN; IMPULSE CONTROL DISORDER; INTERNET ADDICTION; KLEPTOMANIA; NARCOTIC DEPENDENCE; NEUROBIOLOGY; PATHOLOGIC SKIN PRICKING; PATHOLOGICAL GAMBLING; REVIEW; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BEHAVIOR, ADDICTIVE; COMORBIDITY; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; PERSONALITY; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77956306597     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2010.491884     Document Type: Review

References (102)

1. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction 2006; 101:142-151.
2. Potenza MN, Koran LM, Pallanti S. The relationship between impulsecontrol disorders and obsessive-compulsive disorder: A current understanding and future research directions. Psychiatry Res 2009; 170:22-31.
3. Holden C. Behavioral addictions debut in proposed DSM-V. Science 2010; 327:935.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision (DSM-IV-TR). Washington, DC: American Psychiatric Publishing, Inc., 2000.
5. Chambers RA, Potenza MN. Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud 2003; 19:53-84.
6. SlutskeWS. Natural recovery and treatment-seeking in pathological gambling: Results of two U.S. national surveys. Am J Psychiatry 2006; 163:297-302.
7. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 2008; 75:63-75.
8. de Castro V, Fong T, Rosenthal RJ, Tavares H. A comparison of craving and emotional states between pathological gamblers and alcoholics. Addict Behav 2007; 32:1555-1564.
9. Blanco C, Moreyra P, Nunes EV, Sáiz-Ruiz J, Ibáñez A. Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry 2001; 6:167-176.
10. Grant JE, Brewer JA, Potenza MN. The neurobiology of substance and behavioral addictions. CNS Spectr 2006; 11:924-930.
11. Grant JE, Potenza MN. Gender-related differences in individuals seeking treatment for kleptomania. CNS Spectr 2008; 13:235-245.
12. Grant JE, Kim SW. Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry 2001; 62:957-962.
13. Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, OMalley SS. Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry 2001; 158:1500-1505.
14. Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am 1999; 22:241-252.
15. Ledgerwood DM, Weinstock J, Morasco BJ, Petry NM. Clinical features and treatment prognosis of pathological gamblers with and without recent gambling-related illegal behavior. J Am Acad Psychiatry Law 2007; 35:294-301.
16. Lejoyeux M, Tassain V, Solomon J, Adès J. Study of compulsive buying in depressed patients. J Clin Psychiatry 1997; 58:169-173.
17. Kim SW, Grant JE. Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Res 2001; 104:205-212.
18. Grant JE, Kim SW. Temperament and early environmental influences in kleptomania. Compr Psychiatry 2002; 43:223-228.
19. Raymond NC, Coleman E, Miner MH. Psychiatric comorbidity and compulsive/ impulsive traits in compulsive sexual behavior. Compr Psychiatry 2003; 44:370-380.
20. Kelly TH, Robbins G, Martin CA, Fillmore MT, Lane SD, Harrington NG, Rush CR. Individual differences in drug abuse vulnerability: d- Amphetamine and sensation-seeking status. Psychopharmacology (Berl) 2006; 189:17-25.
21. Tavares H, Gentil V. Pathological gambling and obsessive-compulsive disorder: Towards a spectrum of disorders of volition. Rev Bras Psiquiatr 2007; 29:107-117.
22. Blanco C, Potenza MN, Kim SW, Ibáñez A, Zaninelli R, Saiz-Ruiz J, Grant JE. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res 2009; 167:161-168.
23. Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 2006; 163:1282-1284.
24. Odlaug BL, Grant JE, Chamberlain SR. Motor inhibition and cognitive flexibility in pathological skin picking. Prog Neuropharm Biol Psych 2010; 34:208-211.
25. Cunningham-Williams RM, Cottler LB, Compton WM 3rd, Spitznagel EL. Taking chances: problem gamblers and mental health disorders-Results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health 1998; 88:1093-1096.
26. Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005; 66:564-574.
27. Bland RC, Newman SC, Orn H, Stebelsky G. Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 1993; 38:108-112.
28. el-Guebaly N, Patten SB, Currie S, Williams JV, Beck CA, Maxwell CJ, Wang JL. Epidemiological associations between gambling behavior, substance use & mood and anxiety disorders. J Gambl Stud 2006; 22:275-287.
29. Welte JW, Barnes GM, Tidwell MC, Hoffman JH. The prevalence of problem gambling among U.S. adolescents and young adults: Results from a national survey. J Gambl Stud 2008; 24:119-133.
30. Yen JY, Ko CH, Yen CF, Chen CS, Chen CC. The association between harmful alcohol use and Internet addiction among college students: Comparison of personality. Psychiatry Clin Neurosci 2009; 63:218-224.
31. Stinchfield R, KushnerMG,Winters KC. Alcohol use and prior substance abuse treatment in relation to gambling problem severity and gambling treatment outcome. J Gambl Stud 2005; 21:273-297.
32. Duhig AM, Maciejewski PK, Desai RA, Krishnan-Sarin S, Potenza MN. Characteristics of adolescent past-year gamblers and non-gamblers in relation to alcohol drinking. Addict Behav 2007; 32:80-89.
33. Grant JE, Potenza MN. Tobacco use and pathological gambling. Ann Clin Psychiatry 2005; 17:237-241.
34. Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, Krishnan-Sarin S, George TP, OMalley SS. Characteristics of tobaccosmoking problem gamblers calling a gambling helpline. Am J Addict 2004; 13:471-493.
35. Presta S, Marazziti D, DellOsso L, Pfanner C, Pallanti S, Cassano GB. Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry 2002; 43:7-12.
36. Di Nicola M, Tedeschi D, Mazza M, Martinotti G, Harnic D, Catalano V, Bruschi A, Pozzi G, Bria P, Janiri L. Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions. J Affect Disord 2010; [ePub ahead of print doi:10.1016/j.jad.2009.12.016].
37. Petry NM, Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug Alcohol Depend 1999; 56:25-32.
38. Bechara A. Risky business: emotion, decision-making, and addiction. J Gambl Stud 2003; 19:23-51.
39. Cavedini P, Riboldi G, Keller R, DAnnucci A, Bellodi L. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry 2002; 51:334-341.
40. Ko CH, Hsiao S, Liu GC, Yen JU, Yang MJ, Yen CF. The characteristics of decision making, potential to take risks, and personality of college students with Internet addiction. Psychiatry Res 2010; 175:121-125.
41. Goudriaan AE, Oosterlaan J, de Beurs E, Van Den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 2006; 101:534-547.
42. Potenza MN. Review. The neurobiology of pathological gambling and drug addiction: An overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008; 363:3181-3189.
43. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, BecharaA, Sahakian BJ,Robbins TW,Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: A narrative review. Neuropsychopharmacology 2010; 35:591-604.
44. Blanco C, Orensanz-Muñoz L, Blanco-Jerez C, Saiz-Ruiz J. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996; 153:119-121.
45. Hollander E, Kwon J,Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Res 1998; 79:213-217.
46. Dagher A, Robbins TW. Personality, addiction, dopamine: Insights from Parkinsons disease. Neuron 2009; 61:502-510.
47. OSullivan SS, Evans AH, Lees AJ.Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 2009; 23:157-170.
48. Zack M, Poulos CX. Parallel roles for dopamine in pathological gambling and psychostimulant addiction. Curr Drug Abuse Rev 2009; 2:11-25.
49. Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, Skudlarski P,Gore JC. An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003; 160:1990-1994.
50. London ED, Ernst M, Grant S, Bonson K, Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 2000; 10:334-342.
51. Ko CH, Liu GC, Hsiao S, Yen JY, Yang MJ, Lin WC, Yen CF, Chen CS. Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res 2009; 43:739-747.
52. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8:147-148.
53. Wrase J, Schlagenhauf F, Kienast T, Wüstenberg T, Bermpohl F, Kahnt T, Beck A, Ströhle A, Juckel G, Knutson B, Heinz A. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 2007; 35:787-794.
54. SteevesTD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G,VanEimeren T, Rusjan P, Houle S, Strafella AP. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain 2009;132:1376-1385.
55. Bradberry CW. Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: Areas of agreement, disagreement, and implications for addiction. Psychopharmacology (Berl) 2007; 191:705-717.
56. Weintraub D, Potenza MN. Impulse control disorders in Parkinsons disease. Curr Neurol Neurosci Rep 2006; 6:302-306.
57. Voon V, Fernagut P-O, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E. Chronic dopaminergic stimulaton in Parkinsons disease: From dyskinesias to impulse control disorders. Lancet Neurol 2009; 8:1140-1149.
58. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67:1254-1257.
59. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63: 969-973.
60. Zack M, Poulos CX. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 2007; 32:1678-1686.
61. Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. A doubleblind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 2008; 89: 298-303.
62. McElroy SL, Nelson EB,Welge JA, Kaehler L, Keck PE Jr. Olanzapine in the treatment of pathological gambling: A negative randomized placebocontrolled trial. J Clin Psychiatry 2008; 69:433-440.
63. Black DW, Monahan PO, Temkit M, Shaw M. A family study of pathological gambling. Psychiatry Res 2006; 141:295-303.
64. Grant JE. Family history and psychiatric comorbidity in persons with kleptomania. Compr Psychiatry 2003; 44:437-441.
65. Black DW, Repertinger S, Gaffney GR, Gabel J. Family history and psychiatric comorbidity in persons with compulsive buying: Preliminary findings. Am J Psychiatry 1998; 155:960-963.
66. Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 2000; 57:666-673.
67. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55:967-972.
68. Comings DE. Why different rules are required for polygenic inheritance: Lessons from studies of the DRD2 gene. Alcohol 1998; 16:61-70.
69. Hamidovic A, Dlugos A, Skol A, Palmer AA, de Wit H. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: An exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol 2009; 17:374-383.
70. Lee Y, Han D, Yang K, Daniels M, Na C, Kee B, Renshaw P. Depressionlike characteristics of 5HTTLPR polymorphism and temperament in excessive internet users. Journal of Affective Disorders 2009; 109:165-169.
71. Petry NM, Ammerman Y, Bohl J, Doersch A, Gay H, Kadden R, Molina C, Steinberg K. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol 2006; 74:555-567.
72. Teng EJ,WoodsDW, TwohigMP. Habit reversal as a treatment for chronic skin picking: a pilot investigation. Behav Modif 2006; 30:411-422.
73. Mitchell JE, Burgard M, Faber R, Crosby RD, de Zwaan M. Cognitive behavioral therapy for compulsive buying disorder. Behav Res Ther 2006; 44:1859-1865.
74. Toneatto T, Dragonetti R. Effectiveness of community-based treatment for problem gambling: A quasi-experimental evaluation of cognitivebehavioral vs. twelve-step therapy. Am J Addict 2008; 17:298-303.
75. Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M. 12-month follow-up study of drug treatment in pathological gamblers: A primary outcome study. J Clin Psychopharmacol 2007; 27:620-624.
76. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49:914-921.
77. Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006; 163:303-312.
78. Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 2008; 69:783-789.
79. Grant JE, Kim SW, Odlaug BL. A double-blind, placebo-controlled trial of the opioid antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry 2009; 65:600-606.
80. Grant JE. Three cases of compulsive buying treated with naltrexone. Int J Psychiatr Clin Practice 2003; 7:223-225.
81. Raymond NC, Grant JE, Kim SW, Coleman E. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: Two case studies. Int Clin Psychopharmacol 2002; 17:201-205.
82. Bostwick JM, Bucci JA. Internet sex addiction treated with naltrexone. Mayo Clin Proc 2008; 83:226-230.
83. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15:351-359.
84. Insel TR, Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. Am J Psychiatry 1983; 140:1219-1220.
85. Roncero C, Rodriguez-Urrutia A, Grau-Lopez L, Casas M. Antiepilectic drugs in the control of the impulses disorders. Actas Esp Psiquiatr 2009; 37:205-212.
86. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, OMalley SS, Swift RM. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007; 298:1641-1651.
87. Johnson BA, Swift RM, Addolorato G, Ciraulo DA, Myrick H. Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res 2005; 29:248-254.
88. Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, OBrien, CP. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 2004; 75:233-240.
89. Grant JE, Kim SW, OdlaugBL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study. Biol Psychiatry 2007; 62:652-657.
90. LaRowe SD, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A, Brady K, Kalivas PW, Malcolm R. Is cocaine desire reduced by Nacetylcysteine? Am J Psychiatry 2007; 164:1115-1117.
91. Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:389-394.
92. Kalivas PW, Hu XT. Exciting inhibition in psychostimulant addiction. Trends Neurosci 2006; 29:610-616.
93. Black DW. Compulsive buying: A review. J Clin Psychiatry 1996; 57:50-54.
94. Ko CH, Yen JY, Chen SH, Yang MJ, Lin HC, Yen CF. Proposed diagnostic criteria and the screening and diagnosing tool of Internet addiction in college students. Compr Psychiatry 2009; 50:378-384.
95. Porter G, Starcevic V, Berle D, Fenech P. Recognizing problem video game use. Aust N Z J Psychiatry 2010; 44:120-128.
96. Goodman A. Sexual addiction: Designation and treatment. J Sex Marital Ther 1992; 18:303-314.
97. Hollander E, Wong CM. Body dysmorphic disorder, pathological gambling, and sexual compulsions. J Clin Psychiatry 1995; 56:7-12.
98. Lochner C, Stein DJ. Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessivecompulsive disorder? Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:353-361.
99. Grant JE. Novel pharmacological targets for reward inhibition in pathological gambling. Presented at the Symposium on Translational Studies of Pathological Gambling at American College of Neuropsychopharmacology, 48th Annual Meeting, Hollywood, FL, 2009.
100. LochnerC,Hemmings SM,Kinnear CJ,NiehausDJ, Nel DG, CorfieldVA, Moolman-Smook JC, Seedat S, Stein DJ. Cluster analysis of obsessivecompulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry 2005; 46:14-19.
101. Potenza MN. The importance of animal models of decision making, gambling, and related behaviors: implications for translational research in addiction. Neuropsychopharmacology 2009; 34:2623-2624.
102. Grant JE. Impulse Control Disorders: A Clinicians Guide to Understanding and Treating Behavioral Addictions. New York, NY: Norton Press, 2008.